N-[(1R,2S)-1-({[5-[(Dimethylamino)methyl]-2-(trifluoromethoxy)phenyl]amino}carbonyl)-2-(1H-indol-3-yl)propyl]-4-(4-fluoro-2-methylphenyl)-3-oxopiperazine-1-carboxamide

ID: ALA4217405

PubChem CID: 11563877

Max Phase: Preclinical

Molecular Formula: C34H36F4N6O4

Molecular Weight: 668.69

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(F)ccc1N1CCN(C(=O)N[C@@H](C(=O)Nc2cc(CN(C)C)ccc2OC(F)(F)F)[C@@H](C)c2c[nH]c3ccccc23)CC1=O

Standard InChI:  InChI=1S/C34H36F4N6O4/c1-20-15-23(35)10-11-28(20)44-14-13-43(19-30(44)45)33(47)41-31(21(2)25-17-39-26-8-6-5-7-24(25)26)32(46)40-27-16-22(18-42(3)4)9-12-29(27)48-34(36,37)38/h5-12,15-17,21,31,39H,13-14,18-19H2,1-4H3,(H,40,46)(H,41,47)/t21-,31+/m0/s1

Standard InChI Key:  HUSUOHXIMXAZBI-JCOAXYOVSA-N

Molfile:  

     RDKit          2D

 48 52  0  0  0  0  0  0  0  0999 V2000
   11.6553   -4.3542    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.0775   -4.9362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8704   -5.1456    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.0496  -10.6589    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.3416  -11.0622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3354  -11.8794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0414  -12.2933    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.7536  -11.8859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7556  -11.0687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0557   -9.8418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7637   -9.4344    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.3497   -9.4279    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.0394  -13.1105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3517   -8.6107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6457   -8.1968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6518   -7.3796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9787   -9.4985    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7857   -9.3728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9153   -8.5677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1904   -8.1900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9832   -7.4010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1974   -7.1861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6147   -7.7601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8220   -8.5532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6119   -8.7681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0638   -8.2074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7698   -8.6172    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.0658   -7.3902    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.7780   -6.9828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7800   -6.1656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4921   -5.7624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1981   -6.1721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1920   -6.9893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4840   -7.3967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0740   -5.7559    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.8980   -7.4032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6060   -6.9958    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.6122   -6.1786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3120   -7.4097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3755   -4.5248    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.3310  -13.5151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3286  -14.3315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0358  -14.7426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7469  -14.3314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7457  -13.5163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0349  -15.5598    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.6248  -12.2830    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.4527  -13.1065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  4  9  1  0
 10 11  2  0
 10 12  1  0
  4 10  1  0
  7 13  1  0
 14 15  1  0
 15 16  1  6
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 17 25  1  0
 20 25  2  0
 15 19  1  0
 26 27  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 29 34  2  0
 35  2  1  0
 30 35  1  0
 37 38  1  0
 37 39  1  0
 36 37  1  0
 33 36  1  0
 28 29  1  0
 26 28  1  0
 14 26  1  0
 14 12  1  6
  2 40  1  0
 13 41  2  0
 41 42  1  0
 42 43  2  0
 43 44  1  0
 44 45  2  0
 45 13  1  0
 43 46  1  0
  6 47  2  0
 45 48  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4217405

    CID 11563877

Associated Targets(Human)

SSTR1 Tclin Somatostatin receptor 1 (861 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SSTR5 Tclin Somatostatin receptor 5 (1477 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SSTR4 Tclin Somatostatin receptor 4 (1125 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SSTR3 Tclin Somatostatin receptor 3 (1562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SSTR2 Tclin Somatostatin receptor 2 (1526 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 668.69Molecular Weight (Monoisotopic): 668.2734AlogP: 5.74#Rotatable Bonds: 9
Polar Surface Area: 110.01Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.67CX Basic pKa: 8.16CX LogP: 5.54CX LogD: 4.71
Aromatic Rings: 4Heavy Atoms: 48QED Weighted: 0.20Np Likeness Score: -1.46

References

1. Banno Y, Sasaki S, Kamata M, Kunitomo J, Miyamoto Y, Abe H, Taya N, Oi S, Watanabe M, Urushibara T, Hazama M, Niwa SI, Miyamoto S, Horinouchi A, Kuroshima KI, Amano N, Matsumoto SI, Matsunaga S..  (2017)  Design and synthesis of a novel series of orally active, selective somatostatin receptor 2 agonists for the treatment of type 2 diabetes.,  25  (21): [PMID:28988629] [10.1016/j.bmc.2017.09.031]

Source